TY - JOUR A1 - Madrid-Gambin, Francisco A1 - Gomez-Gomez, Alex A1 - Busquets-Garcia, Arnau A1 - Haro, Noemí A1 - Marco, Santiago A1 - Mason, Natasha L. A1 - Reckweg, Johannes T. A1 - Mallaroni, Pablo A1 - Kloft, Lilian A1 - Oorsouw, Kim van A1 - Tönnes, Stefan W. A1 - Torre, Rafael de la A1 - Ramaekers, Johannes Gerardus A1 - Pozo, Oscar Jeśus T1 - Metabolomics and integrated network analysis reveal roles of endocannabinoids and large neutral amino acid balance in the ayahuasca experience T2 - Biomedicine & pharmacotherapy N2 - There has been a renewed interest in the potential use of psychedelics for the treatment of psychiatric conditions. Nevertheless, little is known about the mechanism of action and molecular pathways influenced by ayahuasca use in humans. Therefore, for the first time, our study aims to investigate the human metabolomics signature after consumption of a psychedelic, ayahuasca, and its connection with both the psychedelic-induced subjective effects and the plasma concentrations of ayahuasca alkaloids. Plasma samples of 23 individuals were collected both before and after ayahuasca consumption. Samples were analysed through targeted metabolomics and further integrated with subjective ratings of the ayahuasca experience (i.e., using the 5-Dimension Altered States of Consciousness Rating Scale [ASC]), and plasma ayahuasca-alkaloids using integrated network analysis. Metabolic pathways enrichment analysis using diffusion algorithms for specific KEGG modules was performed on the metabolic output. Compared to baseline, the consumption of ayahuasca increased N-acyl-ethanolamine endocannabinoids, decreased 2-acyl-glycerol endocannabinoids, and altered several large-neutral amino acids (LNAAs). Integrated network results indicated that most of the LNAAs were inversely associated with 9 out of the 11 subscales of the ASC, except for tryptophan which was positively associated. Several endocannabinoids and hexosylceramides were directly associated with the ayahuasca alkaloids. Enrichment analysis confirmed dysregulation in several pathways involved in neurotransmission such as serotonin and dopamine synthesis. In conclusion, a crosstalk between the circulating LNAAs and the subjective effects is suggested, which is independent of the alkaloid concentrations and provides insights into the specific metabolic fingerprint and mechanism of action underlying ayahuasca experiences. KW - Ayahuasca KW - Dimethyltryptamine KW - Integrative Network Analysis KW - Metabolomics KW - Psychedelics KW - Subjective effects Y1 - 2022 UR - http://publikationen.ub.uni-frankfurt.de/frontdoor/index/index/docId/78631 UR - https://nbn-resolving.org/urn:nbn:de:hebis:30:3-786316 SN - 1950-6007 N1 - We would like to acknowledge the Dutch Research Council (NWO, grant number 406.18. GO.019), the Departament d′Universitats, Recerca i Societat de la Informació de la Generalitat de Catalunya (expedient 2017 SGR 1721); the Comissionat per a Universitats i Recerca del DIUE de la Generalitat de Catalunya; and the European Social Fund (ESF). Additional financial support has been provided by the Institut de Bioenginyeria de Catalunya (IBEC). IBEC is a member of the CERCA Programme/Generalitat de Catalunya. VL - 149 IS - art. 112845 SP - 1 EP - 10 PB - Elsevier Science CY - Amsterdam [u.a.] ER -